Antonios G.A. Kolios

3.1k total citations
57 papers, 1.2k citations indexed

About

Antonios G.A. Kolios is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, Antonios G.A. Kolios has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 15 papers in Dermatology and 12 papers in Rheumatology. Recurrent topics in Antonios G.A. Kolios's work include Psoriasis: Treatment and Pathogenesis (12 papers), T-cell and B-cell Immunology (12 papers) and Dermatology and Skin Diseases (10 papers). Antonios G.A. Kolios is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (12 papers), T-cell and B-cell Immunology (12 papers) and Dermatology and Skin Diseases (10 papers). Antonios G.A. Kolios collaborates with scholars based in Switzerland, United States and Germany. Antonios G.A. Kolios's co-authors include Lars E. French, Alexander A. Navarini, George C. Tsokos, Onur Boyman, David Klatzmann, Katrin Kerl, Jakob Nilsson, Emmanuel Contassot, Miro E. Raeber and Samuel Gehrke and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Nature Reviews Drug Discovery.

In The Last Decade

Antonios G.A. Kolios

56 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonios G.A. Kolios Switzerland 20 477 397 232 191 187 57 1.2k
Müzeyyen Gönül Türkiye 17 196 0.4× 382 1.0× 163 0.7× 128 0.7× 144 0.8× 124 1.0k
Till Assmann Germany 9 488 1.0× 395 1.0× 121 0.5× 79 0.4× 130 0.7× 18 1.0k
Daisy I. Picavet Netherlands 19 429 0.9× 146 0.4× 141 0.6× 272 1.4× 111 0.6× 29 1.0k
Christopher Hull United States 20 202 0.4× 338 0.9× 389 1.7× 317 1.7× 192 1.0× 58 1.3k
Aikaterini Patsatsi Greece 23 452 0.9× 676 1.7× 409 1.8× 128 0.7× 364 1.9× 126 1.6k
Mariateresa Rossi Italy 18 184 0.4× 428 1.1× 236 1.0× 122 0.6× 104 0.6× 85 941
Hajime Nakano Japan 18 198 0.4× 259 0.7× 136 0.6× 434 2.3× 130 0.7× 117 1.2k
Isabelle Masouyé Switzerland 19 158 0.3× 343 0.9× 216 0.9× 320 1.7× 147 0.8× 56 1.1k
Anikó Kapitány Hungary 22 234 0.5× 297 0.7× 328 1.4× 111 0.6× 402 2.1× 41 1.2k
Efstratios Vakirlis Greece 18 171 0.4× 567 1.4× 309 1.3× 84 0.4× 75 0.4× 95 965

Countries citing papers authored by Antonios G.A. Kolios

Since Specialization
Citations

This map shows the geographic impact of Antonios G.A. Kolios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonios G.A. Kolios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonios G.A. Kolios more than expected).

Fields of papers citing papers by Antonios G.A. Kolios

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonios G.A. Kolios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonios G.A. Kolios. The network helps show where Antonios G.A. Kolios may publish in the future.

Co-authorship network of co-authors of Antonios G.A. Kolios

This figure shows the co-authorship network connecting the top 25 collaborators of Antonios G.A. Kolios. A scholar is included among the top collaborators of Antonios G.A. Kolios based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonios G.A. Kolios. Antonios G.A. Kolios is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wei, Antonios G.A. Kolios, Wenliang Pan, et al.. (2025). Gluconolactone restores immune regulation and alleviates skin inflammation in lupus-prone mice and in patients with cutaneous lupus. Science Translational Medicine. 17(786). eadp4447–eadp4447. 5 indexed citations
2.
Kündig, Thomas M., Thierry Passeron, Julien Sénéschal, et al.. (2025). Regulatory T Cell Dysregulation in Vitiligo: A Meta‐Analysis and Systematic Review of Immune Mechanisms and Therapeutic Perspectives. International Journal of Dermatology. 64(12). 2247–2256. 1 indexed citations
3.
Özcan, Alaz, Víctor Collado‐Díaz, Cecilie Egholm, et al.. (2022). CCR7-guided neutrophil redirection to skin-draining lymph nodes regulates cutaneous inflammation and infection. Science Immunology. 7(68). eabi9126–eabi9126. 27 indexed citations
4.
Sievi, Noriane A., Alexandra Schneider, Martin Osswald, et al.. (2022). The prevalence of obstructive sleep apnea in sarcoidosis and its impact on sleepiness, fatigue, and sleep-associated quality of life: a cross-sectional study with matched controls (the OSASA study). Journal of Clinical Sleep Medicine. 18(10). 2415–2422. 5 indexed citations
5.
Maul, Julia‐Tatjana, Florian Anzengruber, Curdin Conrad, et al.. (2021). Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway. Dermatology. 237(2). 166–178. 27 indexed citations
6.
7.
Maul, Julia‐Tatjana, Urs C. Steiner, Peter Jandus, et al.. (2020). Efficacy of Omalizumab in Mastocytosis: Allusive Indication Obtained from a Prospective, Double-Blind, Multicenter Study (XOLMA Study). Dermatology. 236(6). 529–539. 17 indexed citations
8.
Özcan, Alaz, Dilara Şahin, Daniela Impellizzieri, et al.. (2019). Nanoparticle-Coupled Topical Methotrexate Can Normalize Immune Responses and Induce Tissue Remodeling in Psoriasis. Journal of Investigative Dermatology. 140(5). 1003–1014.e8. 37 indexed citations
9.
Sundin, Mikael, Per Marits, Kim Ramme, Antonios G.A. Kolios, & Jakob Nilsson. (2019). Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C. Clinical Immunology. 200. 16–18. 5 indexed citations
10.
Roth‐Walter, Franziska, Ian M. Adcock, Cristina Benito‐Villalvilla, et al.. (2018). Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper. Allergy. 74(3). 432–448. 31 indexed citations
11.
Maul, Julia‐Tatjana, Stefanie von Felten, Antonios G.A. Kolios, et al.. (2017). Supplementary Material for: Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis Registry. Figshare. 1 indexed citations
12.
Kolios, Antonios G.A., Alissa Gübeli, Barbara Meier, et al.. (2017). Clinical Disease Patterns in a Regional Swiss Cohort of 34 Pyoderma Gangrenosum Patients. Dermatology. 233(4). 268–276. 19 indexed citations
13.
Kolios, Antonios G.A., Nikhil Yawalkar, Mark Anliker, et al.. (2016). Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris. Dermatology. 232(4). 385–406. 31 indexed citations
14.
Boyman, Onur, Antonios G.A. Kolios, & Miro E. Raeber. (2015). Modulation of T cell responses by IL-2 and IL-2 complexes. PubMed. 33(4 Suppl 92). S54–7. 39 indexed citations
15.
Kolios, Antonios G.A., Lars E. French, & Alexander A. Navarini. (2015). Detection of Small Changes in Psoriasis Intensity with PrecisePASI. Dermatology. 230(4). 314–317. 4 indexed citations
16.
Bouchaud, Grégory, Samuel Gehrke, Carsten Krieg, et al.. (2013). Epidermal IL-15Rα acts as an endogenous antagonist of psoriasiform inflammation in mouse and man. The Journal of Experimental Medicine. 210(10). 2105–2117. 54 indexed citations
17.
Kistowska, Magdalena, Samuel Gehrke, Dragana Janković, et al.. (2013). IL-1β Drives Inflammatory Responses to Propionibacterium acnes In Vitro and In Vivo. Journal of Investigative Dermatology. 134(3). 677–685. 177 indexed citations
18.
Kreuter, Alexander, et al.. (2012). Skleromyxödem. Zeitschrift für Rheumatologie. 71(6). 504–514. 5 indexed citations
19.
Gambichler, Thilo, et al.. (2011). Significantly increased CCL5/RANTES and CCR7 mRNA levels in localized scleroderma. Regulatory Peptides. 170(1-3). 4–6. 15 indexed citations
20.
Navarini, Alexander A., Jürgen Bauer, Marjam J. Barysch, et al.. (2011). Spitzoid melanoma and micrometastases in two lymph node regions: a critical situation. European Journal of Dermatology. 21(2). 229–233. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Müzeyyen Gönül Breakdown of academic impact, for papers by Till Assmann Breakdown of academic impact, for papers by Daisy I. Picavet Breakdown of academic impact, for papers by Christopher Hull Breakdown of academic impact, for papers by Aikaterini Patsatsi Breakdown of academic impact, for papers by Mariateresa Rossi Breakdown of academic impact, for papers by Hajime Nakano Breakdown of academic impact, for papers by Isabelle Masouyé Breakdown of academic impact, for papers by Anikó Kapitány Breakdown of academic impact, for papers by Efstratios Vakirlis
Rankless by CCL
2026